Suppr超能文献

低分子量硫醇解毒的药代动力学及作用机制

Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols.

作者信息

Brock N, Hilgard P, Pohl J, Ormstad K, Orrenius S

出版信息

J Cancer Res Clin Oncol. 1984;108(1):87-97. doi: 10.1007/BF00390979.

Abstract

A number of thiol compounds have been studied with reference to their selective protective action against urotoxic side-effects of oxazaphosphorine cytostatics. The uroprotective capacity is determined exclusively by the pharmacokinetic behavior of the compound. When given PO, all compounds tested were absorbable from the gut. Both thiols and disulfides are rapidly eliminated from the blood, but during their short half-life a number of unknown chemical reactions probably take place to maintain a physiological redox equilibrium. Elimination from the blood plasma occurs via two fundamentally different mechanisms: by distribution throughout the tissues and intracellular uptake or, alternatively, by rapid renal excretion. Most of the compounds tested belong to the first group: N-acetylcysteine, carboxycysteine, disulfiram and its metabolite DDTC, glutathione, WR 2721, etc. Few compounds are quantitatively excreted through the urine: mesna, dimesna, and DA 12. Only these compounds were suitable for selective regional detoxification and for the prevention of oxazaphosphorine-induced urotoxic lesions.

摘要

已经对多种硫醇化合物进行了研究,以探讨它们对氧氮磷啶类细胞抑制剂的泌尿毒性副作用的选择性保护作用。泌尿保护能力完全由化合物的药代动力学行为决定。口服给药时,所有测试的化合物都可从肠道吸收。硫醇和二硫化物都能迅速从血液中消除,但在它们较短的半衰期内,可能会发生一些未知的化学反应以维持生理氧化还原平衡。血浆中的消除通过两种根本不同的机制进行:通过分布到整个组织和细胞内摄取,或者通过快速肾脏排泄。大多数测试的化合物属于第一组:N-乙酰半胱氨酸、羧基半胱氨酸、双硫仑及其代谢产物二乙基二硫代氨基甲酸钠、谷胱甘肽、WR 2721等。很少有化合物通过尿液定量排泄:美司钠、二巯基丁二酸钠和DA 12。只有这些化合物适用于选择性区域解毒和预防氧氮磷啶引起的泌尿毒性损伤。

相似文献

引用本文的文献

6
Ifosfamide clinical pharmacokinetics.异环磷酰胺的临床药代动力学。
Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003.
7
The role of active metabolites in drug toxicity.活性代谢物在药物毒性中的作用。
Drug Saf. 1994 Aug;11(2):114-44. doi: 10.2165/00002018-199411020-00006.
9
VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S45-50. doi: 10.1007/BF00647451.
10
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.

本文引用的文献

2
[Principles of toxicological methods].[毒理学方法原理]
Arzneimittelforschung. 1957 Aug;7(8):449-56.
5
[Specific chemotherapy of carcinoma of the prostate].[前列腺癌的特异性化疗]
Klin Wochenschr. 1952 Oct 1;30(37-38):882-4. doi: 10.1007/BF01471475.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验